Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ângela Salvi"'
Autor:
Luciana Santos Dubeux, Gisele Cazarin, Ana Claudia Figueiró, Luciana Caroline Albuquerque Bezerra, Marcos Barros, Ângela Salvi, Dulcineide Oliveira, Gustavo Sampaio
Publikováno v:
Revista Brasileira de Saúde Materno Infantil, Vol 7, Pp s47-s52 (2007)
Será apresentada neste artigo a proposta do Curso Básico de Avaliação em Saúde do Instituto Materno Infantil Prof. Fernando Figueira - IMIP - voltada ao ensino dos principais conceitos e abordagens nesse campo de atuação, com o uso de fundamen
Externí odkaz:
https://doaj.org/article/0d2fd6861a6c4d5b8343f49c2ec482f0
Autor:
Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio, Lucia Fiorillo, Nicoletta Staropoli, Domenico Ciliberto, Alessia Cordua, Francesca Scionti, Bernardo Bertucci, Angela Salvino, Mariangela Lopreiato, Fredrik Thunarf, Onofrio Cuomo, Maria Cristina Zito, Maria Rosanna De Fina, Amelia Brescia, Simona Gualtieri, Caterina Riillo, Francesco Manti, Daniele Caracciolo, Vito Barbieri, Eugenio Donato Di Paola, Adele Emanuela Di Francesco, Pierosandro Tagliaferri
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-12 (2023)
Abstract Background We developed a 13-mer locked nucleic acid (LNA) inhibitor of miR-221 (LNA-i-miR-221) with a full phosphorothioate (PS)-modified backbone. This agent downregulated miR-221, demonstrated anti-tumor activity against human xenografts
Externí odkaz:
https://doaj.org/article/4d9a753abc2e49c2bbde30064f04d177
Autor:
Nicoletta Staropoli, Angela Salvino, Federica Falcone, Valentina Farenza, Martina Costa, Giacomo Rossini, Francesco Manti, Antonella Crispino, Caterina Riillo, Domenico Ciliberto, Mariamena Arbitrio, Pierfrancesco Tassone, Pierosandro Tagliaferri
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe optimal strategy for the treatment of recurrent and/or advanced endometrial cancer is still undefined. Recently, despite the lack of any predictive biomarker, the combination of pembrolizumab with lenvatinib has improved survival outcom
Externí odkaz:
https://doaj.org/article/ff6871284696474fbf16f570be46d30f
Autor:
Nicoletta Staropoli, Mariamena Arbitrio, Angela Salvino, Francesca Scionti, Domenico Ciliberto, Rossana Ingargiola, Caterina Labanca, Giuseppe Agapito, Eleonora Iuliano, Vito Barbieri, Maria Cucè, Valeria Zuccalà, Mario Cannataro, Pierfrancesco Tassone, Pierosandro Tagliaferri
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1210 (2022)
Carboplatin is the cornerstone of ovarian cancer (OC) treatment, while platinum-response, dependent on interindividual variability, is the major prognostic factor for long-term outcomes. This retrospective study was focused on explorative search of g
Externí odkaz:
https://doaj.org/article/243e782ecef8418599fd7cdcc76fa73a